课题基金 / 基金详情

Reprogramming HSCs to generate protective trained immunity against TB

Reprogramming HSCs to generate protective trained immunity against TB
重新编程 HSC 以产生针对结核病的保护性训练免疫力
批准号：
408301
负责人：
Divangahi Maziar
金额：
$62.98万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-09-01 至 2024-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=408301&lang=en
关键词：
Hematopoietic Stem Cells Immune Response Innate Immunity Respiratory Infection Trained Immunity Tuberculosis

项目摘要

项目成果

Divangahi Maziar的其他基金

相似基金

相关文献

中文摘要
翻译
自从1882年德国科学家罗伯特·科赫首次发现结核分枝杆菌(Mtb)是结核病的感染源以来，它一直无视科学家预防或治愈这种疾病的努力。古埃及人结核分枝杆菌DNA的存在
英文摘要
Ever since German scientist Robert Koch first discovered Mycobacterium tuberculosis (Mtb) to be the infectious agent of tuberculosis in 1882, it has defied efforts by scientists to prevent or cure the disease. The presence of Mtb DNA in ancient Egyptian m
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing a novel vaccine against COVID-19
Targeting the eicosanoid/macrophage axis to enhance host defense against influenza virus infection
Monocyte/Macrophage Biology Symposium: Cracking the Macrophage Code in Host Defense and Tolerance
Regulation of Anti-Microbial Macrophage Response to Pulmonary Infections
海外基金